Physician

Abdul Al-Kassab, MD

According to 2025 Medicare claims, Abdul Al-Kassab, MD (NPI: 1477560308) practices endocrinology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is ENDOCRINE & DIABETES CONSULTANTS PC (NPI: 1144237082; TIN: 383595547) and primary practice location at 48309-3674. Al-Kassab is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), Trinity Health Integrated Care (ACO ID: A3454), West Michigan Accountable Care Organization, LLC (ACO ID: A4626), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Al-Kassab's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,250 traditional Medicare patients, billed 2,852 HCPCS/CPT codes, and received $224,958 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 17,311 prescription claims across 1,880 beneficiaries totaling $8,456,698 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,929 claims. Open Payments data shows 110 records totaling $25,487. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $353,438 to $224,958. In contrast, Part D prescription costs have risen steadily, from $4,533,042 to $8,456,698. For DME billing, reported payments moved sharply higher in recent years, from $38,765 to $526,868.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,625	6,415	$353,438
2016	1,845	7,019	$390,603
2017	1,864	7,475	$384,894
2018	1,718	6,580	$337,426
2019	1,749	6,763	$380,527
2020	1,582	4,893	$315,111
2021	1,535	4,709	$339,176
2022	1,374	3,701	$267,128
2023	1,253	3,292	$254,503
2024	1,250	2,852	$224,958

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,543	12,501	$4,533,042
2016	1,749	14,021	$5,125,854
2017	1,869	15,153	$5,797,627
2018	1,817	14,970	$6,657,009
2019	1,815	14,984	$7,159,072
2020	1,737	14,673	$6,903,094
2021	1,784	15,046	$8,118,529
2022	1,728	15,287	$9,385,945
2023	1,888	17,238	$11,068,944
2024	1,880	17,311	$8,456,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,463	3,404	$116,724
2016	1,455	3,263	$103,111
2017	1,268	2,661	$94,869
2018	1,310	2,955	$154,503
2019	1,198	3,005	$237,585
2020	946	2,966	$335,971
2021	809	2,936	$404,510
2022	665	2,869	$432,377
2023	683	2,912	$486,196
2024	643	1,929	$542,616

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	105	105	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,034	1,638	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	127	303	$65
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	103	270	$41
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	211	347	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	688	39,144	$1,245,523
Jardiance	Empagliflozin	856	62,931	$1,162,570
Korlym	Mifepristone	28	840	$1,123,243
Mounjaro	Tirzepatide	339	14,214	$502,170
Farxiga	Dapagliflozin Propanediol	351	23,010	$412,095

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	239	1,023	$468,449
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	11	26	$14,839
E0784	External ambulatory infusion pump, insulin	Y	N/R	41	$13,352
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	19	53	$12,192
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	43	43	$9,413

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$25,487	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Al-Kassab, MD?

Tedicare shows public-source Medicare data for Abdul Al-Kassab, MD (NPI 1477560308), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Al-Kassab, MD have ACO affiliation data?

Abdul Al-Kassab, MD is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Trinity Health Integrated Care (MSSP, ACO ID A3454), West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Abdul Al-Kassab, MD?

Abdul Al-Kassab, MD is linked to ENDOCRINE & DIABETES CONSULTANTS PC (billing NPI 1144237082) in the available physician profile data.

Does Abdul Al-Kassab, MD have Open Payments data?

Abdul Al-Kassab, MD has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.